Business
Chimeric (ASX:CHM) share price drops despite cancer trial update
Image Source: Getty Images
The Chimeric Therapeutics Ltd (ASX: CHM) share price has fallen today. It coincides with the drug development company’s update on its cancer cell therapy.
At market’s close, the Chimeric share price was trading at 29 cents, down…
Continue Reading
-
Business12 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
General9 hours agoFormer truck driver’s garage memorabilia collection sold to Westonia to drive tourism
-
Noosa News15 hours agoInside the big change in homebuyer habits during the Christmas holidays
-
Noosa News9 hours agoJetstar flights resume across Australia after Airbus A320 software issue identified